Kentucky Board of Pharmacy Hires a New Pharmacy and Drug Inspector

New Pharmacy and Drug Inspector
Amanda Harding, RPh, began working as a pharmacy and drug
inspector for the Board on May 1, 2013. She is a 2008 graduate of the
University of South Carolina College of Pharmacy. Amanda’s pharmacy
background consists primarily of working in community pharmacy. She
was a pharmacy manager for Walgreens from 2009 to 2013. She is a
resident of Louisville, KY, and will be inspecting Louisville and some
surrounding counties.

quoted from Kentucky Board of Pharmacy June 2013 Newsletter

New Mexico Board of Pharmacy Proposed Changes to Compounding Rules

During the April 18-19, 2013, New Mexico Board of Pharmacy
meeting, three regulation changes were made. One of  these
regulation changes is discussed below and relates to compounding

16.19.30.9 NMAC – Compounding of Nonsterile Pharmaceuticals;
Operational Standards. This regulation revision
states that a pharmacy may no longer compound for a prescriber’s
office use. The wording allowing for office use compounding
was removed from the regulation. A compounded
medication may be sold by a pharmacy by prescription only.
The labeled compounded product is sold after receipt of a
valid prescription is issued to a specific patient.
All Board regulation changes are heard in open session
during Board meetings. Links to the proposed changes are
available online. Go to the Board Web site and click on the
agenda for the Board meeting. There you will find a link to
a proposed regulation change. Public and professional comments
are welcome. Please submit comments to the Board
through written correspondence at least 15 days prior to the
Board meeting, or you may appear in person to express your
opinion.

quoted from New Mexico Board of Pharmacy June 2013 Newsletter

CDC Website Regarding Main Street Family Pharmacy

The Centers for Disease Control has established a web site providing twice weekly updates on the investigation of suspected investigations linked to preservative-free methylprednisolone acetate 80 mg/mL injections compounded by Main Street Family Pharmacy.  The CDC website can be viewed here

North Dakota Board of Pharmacy Explains Scheduling of Tramadol

Scheduling of Tramadol
North Dakota House Bill 1070 passed the North Dakota House
and Senate and was signed by Governor Jack Dalrymple. This billincluded revisions to Schedule I through V controlled substances
(CS) based on federal Drug Enforcement Administration scheduling
changes. This year, the bill included scheduling of multiple spiced
cannabinoids and substances marked as bath salts as Schedule I CS.
The other important revision within this bill is the addition
of tramadol and tramadol-containing products as Schedule IV
substances. An initial inventory should have been taken after the
date of scheduling, and the handling of prescriptions for tramadolcontaining
products should conform to the requirements set forward
in state law. As a reminder, North Dakota law does allow electronic
prescribing of CS outside of the stricter federal standards. Since
tramadol, at this time, is only a state CS, the electronic prescribing
of prescriptions for tramadol is not subject to federal regulations.

quoted from North Dakota Board of Pharmacy June 2013 Newsletter